Trial Outcomes & Findings for Bone Graft Particle Size on Bone Vitality and Volume (NCT NCT04778709)
NCT ID: NCT04778709
Last Updated: 2023-12-01
Results Overview
Assessment of the quality of bone that is generated in the grafted sinuses by measuring the: percent vital bone formation, percent of inflammatory tissue if any
TERMINATED
NA
4 participants
After surgery, 8 months, 1 year
2023-12-01
Participant Flow
Unit of analysis: tooth sites
Participant milestones
| Measure |
Bone Graft A
Bone Graft A: Mixture of 25% small-particle cortical, 25% large particle cortical, 25% small particle cancellous, 25% large particle cancellous allograft
Puros allograft: Bilateral sinus augmentation procedure using the lateral window technique. Graft material combination A or B will be randomly assigned to right and left sinus.
Each subject will receive the following bone allograft material:
Four to six grams of commercially available human donor bone allograft (Puros Allograft Bone Particles, Zimmer Biomet, Palm Beach Gardens, FL USA) consisting of Graft A cortical and cancellous bone chips of both 250-1000 microns and 1000-2000 microns size, or Graft B for contralateral sinus: cancellous 1000-2000 microns size alone.
|
Bone Graft B
Bone Graft B: 100% large particle cancellous allograft
Puros allograft: Bilateral sinus augmentation procedure using the lateral window technique. Graft material combination A or B will be randomly assigned to right and left sinus.
Each subject will receive the following bone allograft material:
Four to six grams of commercially available human donor bone allograft (Puros Allograft Bone Particles, Zimmer Biomet, Palm Beach Gardens, FL USA) consisting of Graft A cortical and cancellous bone chips of both 250-1000 microns and 1000-2000 microns size, or Graft B for contralateral sinus: cancellous 1000-2000 microns size alone.
|
|---|---|---|
|
Overall Study
STARTED
|
2 4
|
2 4
|
|
Overall Study
COMPLETED
|
0 0
|
0 0
|
|
Overall Study
NOT COMPLETED
|
2 4
|
2 4
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Bone Graft Particle Size on Bone Vitality and Volume
Baseline characteristics by cohort
| Measure |
Bone Graft A
n=4 Tooth Sites
Bone Graft A: Mixture of 25% small-particle cortical, 25% large particle cortical, 25% small particle cancellous, 25% large particle cancellous allograft
Puros allograft: Bilateral sinus augmentation procedure using the lateral window technique. Graft material combination A or B will be randomly assigned to right and left sinus.
Each subject will receive the following bone allograft material:
Four to six grams of commercially available human donor bone allograft (Puros Allograft Bone Particles, Zimmer Biomet, Palm Beach Gardens, FL USA) consisting of Graft A cortical and cancellous bone chips of both 250-1000 microns and 1000-2000 microns size, or Graft B for contralateral sinus: cancellous 1000-2000 microns size alone.
|
Bone Graft B
n=4 Tooth Sites
Bone Graft B: 100% large particle cancellous allograft
Puros allograft: Bilateral sinus augmentation procedure using the lateral window technique. Graft material combination A or B will be randomly assigned to right and left sinus.
Each subject will receive the following bone allograft material:
Four to six grams of commercially available human donor bone allograft (Puros Allograft Bone Particles, Zimmer Biomet, Palm Beach Gardens, FL USA) consisting of Graft A cortical and cancellous bone chips of both 250-1000 microns and 1000-2000 microns size, or Graft B for contralateral sinus: cancellous 1000-2000 microns size alone.
|
Total
n=8 Tooth Sites
Total of all reporting groups
|
|---|---|---|---|
|
Age, Customized
18-25 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Customized
26-35 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Customized
36-45 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Customized
46-55 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Customized
56-65 years
|
2 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
1 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Non-Hispanic White
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
2 participants
n=5 Participants
|
2 participants
n=7 Participants
|
4 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: After surgery, 8 months, 1 yearPopulation: Data were not collected. The original PI who is no longer at the institution, the sponsor of this research study, Zimmer Biomet, along with the current PI has decided to close enrollment to the study and to early terminate the study.
Assessment of the quality of bone that is generated in the grafted sinuses by measuring the: percent vital bone formation, percent of inflammatory tissue if any
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: After surgery, 8 months, 1 yearPopulation: Data were not collected. The original PI who is no longer at the institution, the sponsor of this research study, Zimmer Biomet, along with the current PI has decided to close enrollment to the study and to early terminate the study.
Assessment of the quality of bone that is generated in the grafted sinuses by measuring the: percent of residual bone graft material
Outcome measures
Outcome data not reported
PRIMARY outcome
Timeframe: After surgery, 8 months, 1 yearPopulation: Data were not collected. The original PI who is no longer at the institution, the sponsor of this research study, Zimmer Biomet, along with the current PI has decided to close enrollment to the study and to early terminate the study.
Assessment of the quality of bone that is generated in the grafted sinuses by measuring the: percent of inflammatory tissue if any
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: After surgery, 8 months, 1 yearPopulation: Data were not collected. The original PI who is no longer at the institution, the sponsor of this research study, Zimmer Biomet, along with the current PI has decided to close enrollment to the study and to early terminate the study.
Assessment of bone volume stability through CBCT analysis comparing it from the time of placement, 8 months post-grafting and 1 year post-implantation
Outcome measures
Outcome data not reported
Adverse Events
Bone Graft A
Bone Graft B
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place